|
|
Notice (B): Government-Owned Inventions; Availability for Licensing Federal Register: December 31, 2009 (Volume 74, Number 250)
Page 69346-69348
AGENCY: National Institutes of Health, Public Health Service, HHS.
ACTION: Notice.
SUMMARY: The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of Federally-funded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies and may also be available for licensing.
ADDRESSES: Licensing information and copies of the U.S. patent
applications listed below may be obtained by writing to the indicated
licensing contact at the Office of Technology Transfer, National
Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville,
Maryland 20852-3804; telephone: 301/496-7057; fax: 301/402-0220. A
signed Confidential Disclosure Agreement will be required to receive
copies of the patent applications.
Fourier X-ray Scattering and Phase-Contrast Imaging: Enhanced Contrast
and Sensitivity of X-ray Images
Description of Technology: The invention offered for licensing is
broadly applicable to medical diagnostic imaging, biological imaging,
industrial non-destructive testing, security screening, and other
routine x-ray inspections. The invention provides a method and
apparatus that can significantly improve and enhance the contrast and
sensitivity of x-ray images. More specifically, the method described in
the invention provides a technique to obtain in a single shot x-ray
diffraction, differential phase-contrast, as well as the conventional
absorption images. X-ray diffraction reveals information about
microscopic structures in the imaged object from nanometer to
micrometer scales which enables detection of specific materials and
disease pathologies that are invisible in conventional x-ray images.
The main advantage of the invention over prior art is the single-shot
capability without the need to scan an analyzer crystal or grating, and
without the need for any hardware beyond standard radiography
equipment. It also offers flexibility in hardware configuration to
target specific materials by their diffraction signature. For this
reason the invention is highly adaptable and well suited for day-to-day
applications of x-ray radiography and computed tomography.
In one of the embodiments of the invention for example, a
scattering imaging method uses a transmission grid to modulate the
intensity of a beam of an x-ray radiation source. A detector captures a
raw image from the modulated intensity pattern. A diffraction image can
be automatically generated from the detected modulated intensity
pattern.
In yet another embodiment, both a diffraction image and a
differential phase-contrast image are obtained in a single exposure.
Advantageously, commercially available x-ray grids and radiography
machines can be used for this method, and exact positioning of the grid
is unnecessary, as the method works for any non-zero distance between
the grid and the detector. Thus, the speed and ease of implementation
makes it suitable for both planar radiography and 3D computed
tomography. In addition to its medical diagnostics significance, the
invention can be utilized in other, non-medical applications such as
non-destructive inspections and security screening.
Applications
Medical diagnostic radiography and computed tomography.
For example, imaging blood vessels, imaging of bones (i.e.,
osteoporosis, fractures).
Non-invasive characterization of material microscopic
structures by planar radiography or 3D computed tomography
implementations of the invention.
Detection of materials by their diffraction signature in
x-ray inspections and security screening.
Advantages: Although x-ray diffraction and phase-contrast imaging
can detect materials and structures that are invisible by conventional
absorption images, current techniques remain difficult to implement due
to requirements for specialized x-ray optical components and/or
brilliant sources, and lengthy scanning of analyzer components such as
perfect crystals or high-density gratings. A recent publication
(US2007/0183563 A1) mentioned that by using a detector with elements
less than \1/3\ of the pitch of an analyzer grating, it is possible to
obtain differential phase-contrast images in one measurement without
the need to scan. US2007/0183580 A1 further elaborates on this
technique and specifies that the detector elements are an integer
fraction of the grating pitch so that sub-groups of the detectors can
report x-ray intensities of different portions of a grating period,
from which the phase shift of the grating pattern is measured. Such
detectors are highly challenging to realize, and are not able to cope
with varying pitches or patterns of x-ray beam modulation.
It is additionally known in the art to remove the effects of
scattering with the use of grids, gratings, or other masks of
periodically arranged opaque areas. Specifically, a mask or multiple
masks of periodically arranged opaque areas are placed in the x-ray
path, such that periodic dark shadows are created on a recorder surface
either by direct geometric shadowing or by wave-interference effects.
The shadow areas only receive x-ray which is scattered in the object.
The signals of these shadow areas are subtracted from the raw image to
yield an image free of the effects of scattering.
Nonetheless, the above variations require exacting procedures or
are expensive, making the prior art ill-suited for today's routine x-
ray imaging applications, including non-destructive testing (e.g.,
component inspection without damage), security screening, and medical
diagnostic exams.
The present technology overcomes the drawbacks of the prior art by
allowing the acquisition of x-ray diffraction, differential phase-
contrast and absorption images all in a single exposure without the
need for scanning or any hardware beyond commercial radiography
equipment.
It is particularly flexible when compared to prior art in that the
number of transmission grids, their patterns and their positions can
all be adjusted to selectively detect or enhance specific materials,
such as contrast agents in medical diagnostic imaging or explosive
materials in security screening.
Development Status: The invention is fully developed.
[[Page 69347]]
Market: The market for medical imaging equipment industry is
approximately $9.0 billion dollars now and has been growing by
approximately 7.6% annually. X-ray imaging and related instrumentation
constitutes a significant portion of this market.
X-ray radiography is the most common and widely available
diagnostic imaging technique. Even when a diagnostic testing requires
more powerful or sophisticated tests, an x-ray imaging may many times
be needed first before other more sophisticated tests are applied.
X-ray angiography currently provides the best
visualization of blood vessels in the body. The ability of this
technology to selectively enhance contrast agents can eliminate
difficulties associated with subtraction angiography and improve
angiography exams.
The advent of Computed Tomography (CT) and other digital
x-ray technologies have enhanced the capabilities of x-ray imaging and
have resulted in the tremendous growth of x-ray imaging. CT combines x-
rays with computer technology and can produce a highly detailed, cross-
sectional image of the body and organs, tissues or tumors inside the
body. CT scans are now routinely used to diagnose problems with small,
bony structures or in cases of severe trauma to the brain, spinal cord,
chest, abdomen, or pelvis. Furthermore, the introduction of multi-slice
CT has been one of the most significant enhancements ever brought to
the market, and the technological innovations that have been made
within the realm of CT in recent years are revolutionary and should be
the primary drivers for future industry growth. Electron Beam
Technology (EBT) for example is a CT technology that created
opportunities in cardiac diagnostics. CT requires fast and robust image
acquisition, thus the present invention is uniquely able to enhance CT
with diffraction and phase contrast.
The United States market for computed tomography (CT)
scanning systems is estimated to touch $3.6 billion by the end of 2009.
The U.S. accounts for over 50.0 percent of the worldwide market.
Cardiac imaging is a fast expanding CT application due to its utility
in emergency medicine, perfusion studies and CT angiography. While
hospitals started out as the original care site where scanning was
done, independent imaging centers and physician's offices offering
scanning have become widespread in the U.S. over the last decade. With
the advent of portable and mobile CT scans, access and availability of
this imaging modality has increased significantly. Currently it is
estimated that about 25% of scanning stations are in private practices
and imaging centers that are not part of a hospital. Most hospitals
have a range of scanners from low-slice to high-slice. The overall
trend is towards acquiring high-slice scanners which can be similar in
terms of capital costs but far superior in function.
One of the fastest growing applications is CT angiograms,
currently at an annual rate of about half a million in the U.S.
Pediatric usage is also growing. An estimated 6 million CT scans per
year are done for pediatric cases. Of these, about 600,000 are done for
head and abdominal examinations. The ability of the present technology
to highlight certain contrast agents against background tissue and bone
signal can significantly enhance CT angiography.
The women's mammography segment of x-ray imaging is poised
for a major new phase of growth fueled by the availability of new
technology coming out of the computer and digital areas and the higher
interest of individual patients and general healthcare consumers to
take charge of their own health status. Continuous improvements in
technology are resulting in a growing number of new imaging diagnostic
tests that combine high levels of accuracy with rapid, easy-to-use
product formats. Digital mammography is driving more screening
programs.
X-ray inspection in product quality control and in
security screening. The present technology offers the ability to detect
and target materials based on their x-ray diffraction signatures. It
may significantly enhance the sensitivity and specificity of the
inspection.
The present technology provides enhancement in x-ray imaging, thus
its application in x-ray instrumentation, offers excellent commercial
opportunities given the size of the industry.
Inventors: Han Wen (NHLBI).
Related Publications
1. Wen H, Bennett EE, Hegedus MM, Rapacchi S. Fourier X-ray
scattering radiography yields bone structural information. Radiology
2009 Jun;252(3):910-918.
2. Wen H, Bennett E, Hegedus MM, Carroll SC. Spatial harmonic
imaging of X-ray scattering--initial results. IEEE Trans Med Imaging
2008 Aug;27(8):997-1002.
Patent Status: PCT Application No. PCT/US2009/051642 filed 24 Jul
2009 (HHS Reference No. E-248-2009/0-PCT-01).
Licensing Status: Available for licensing.
Licensing Contacts: Uri Reichman, PhD, MBA; 301-435-4616;
UR7a@nih.gov; or John Stansberry, PhD; 301-435-5236;
stansbej@mail.nih.gov.
Collaborative Research Opportunity: The National Heart, Lung, and
Blood Institute, Laboratory of Cardiac Energetics, is seeking
statements of capability or interest from parties interested in
collaborative research to further develop, evaluate, or commercialize
single-shot x-ray diffraction and phase-contrast imaging. Please
contact Denise Crooks at 301-402-5579 or crooksd@nhlbi.nih.gov for more
information.
Non-Contact Total Emission Detection Methods for Multiphoton
Microscopy: Improved Image Fidelity and Biological Sample Analysis
Description of Technology: The technology offered for licensing and
for further development is in the field of multiphoton microscopy
(MPM). More specifically, the invention describes and claims optical
designs that can enhance and extend the capabilities of MPM in spectral
imaging of biological samples. The unique design of the light
collection and the detection optics maximizes the collection of emitted
light, thus increasing the signal and hence the signal-to-noise ratio
(SNR). Improvement in image fidelity will result in improved analysis
of biological samples and thus will favorably impact medical research
and possibly clinical diagnosis. The present technology is a further
improvement on the TED (Total Emission Detection) technology, first
disclosed by Dr. Robert Balaban et al. at the NIH in 2006 and claimed
in U.S. patent application 11/979,600, now allowed (Patent Publication
US-2008-0063345 A1, March 13, 2008). The earlier NIH TED technology
proposed an optical design based on enveloping the entirety of a small
sample in a parabolic mirror/condenser combination so light emanated by
a sample in all directions is redirected to the detector. The present
technology further expands the capabilities of TED as its unique design
employing parabolic, toric and conic mirrors ensures maximum light
collection from large samples in cases where there is only access to
one side of the tissues (e.g., in vivo or ex vivo). This is
accomplished by the redirection of all attainable light (i.e., light
escaping the tissue or a whole animal in the epi and sideway
directions) to the detector.
Applications
Tissue and cell analysis in biomedical research.
Potential applications in clinical diagnostics.
[[Page 69348]]
Advantages: The advent of multiphoton microscopy (MPM) provided
several advantages in comparison to single-photon confocal microscopy.
In particular the nonlinear optics used with this technology, combined
with the elimination of a confocal pinhole aperture, led to direct
sectioning and the use of lower energy photons. This approach preserves
the integrity of the observed object (i.e. tissue) thus improving
imaging results. The technology presented here further enhances the
capabilities of MPM by providing the following advantages:
Increased signal-to-noise ratio.
Enhanced image resolution due to SNR.
Improved analytical capabilities.
Non-contact.
May readily be adaptable to commercial microscopes.
Development Status: The invention is fully developed. Prototype
microscope has been built. May need further validation by rigorous in
vivo testing under a variety of different conditions. Also need to
build the smaller prototype that could screw into normal objective
turrets. Alternative realizations with `integrated optic' structures
are also planned.
Market: Multiphoton microscopy (MPM) has found a niche in the world
of biological imaging as the best noninvasive means of fluorescence
microscopy in tissue explants and living animals. Coupled with
transgenic mouse models of disease and `smart' genetically encoded
fluorescent indicators, its use is now increasing exponentially.
Properly applied, it is capable of measuring calcium transients 500
[mu]m deep in a mouse brain, or quantifying blood flow by imaging
shadows of blood cells as they race through capillaries. One of the
great advantages of optical microscopy is its ability to let scientists
peek beneath the tissue surface and study cellular processes at work.
Over the last two decades, the use of multiphoton microscopy has spread
to all major areas of biological research. As researchers are finding
more and more applications for this powerful technique the need for
enhanced performance and enhanced capabilities is also increasing. The
improvements provided in the present technology are simply added to
existing MPM and therefore present excellent commercial opportunities.
Inventors: Jay R. Knutson (NHLBI).
Related Publications
1. U.S. Patent Application Publication US-2008-0063345 A1, March
13, 2008.
2. Presentation, 7th EBSA European Biophysics Congress, July 11-15,
2009, Genova, Italy (http://EBSA2009.org).
3. CA Combs, AV Smirnov, JD Riley, AH Gandjbakhche, JR Knutson, RS
Balaban. Optimization of multiphoton excitation microscopy by total
emission detection using a parabolic light reflector. J Micros. 2007
Dec;228(Pt3):330-337.
Patent Status: U.S. Provisional Application No. 61/224,772 filed 10
Jul 2009 (HHS Reference No. E-236-2009/0-US-01).
Related Technology: U.S. Patent Application No. 11/979,600 filed 06
Nov 2007, now allowed (HHS Reference No. E-257-2005/0-US-04).
Licensing Status: Available for licensing.
Licensing Contacts: Uri Reichman, PhD, MBA; 301-435-4616;
UR7a@nih.gov; or Michael Shmilovich, JD; 301-435-5019;
shmilovm@mail.nih.gov.
Collaborative Research Opportunity: The NHLBI Laboratory of
Molecular Biophysics is seeking statements of capability or interest
from parties interested in collaborative research to further develop,
evaluate, or commercialize an enhanced method of multiphoton microscopy
that is suitable for the spectral imaging of biological samples. Please
contact Brian W. Bailey, PhD at bbailey@mail.nih.gov for more
information.
Dated: December 24, 2009.
Richard U. Rodriguez,
Director, Division of Technology Development and Transfer, Office of
Technology Transfer, National Institutes of Health.
[FR Doc. E9-31074 Filed 12-30-09; 8:45 am]
BILLING CODE 4140-01-P |